Hejna M - Search Results

1

Pre- and postoperative treatment modalities for esophageal squamous cell carcinoma.

Thallinger CM, Kiesewetter B, Raderer M, Hejna M. Thallinger CM, et al. Among authors: hejna m. Anticancer Res. 2012 Nov;32(11):4609-27. Anticancer Res. 2012. PMID: 23155224 Review.

2

Postoperative chemotherapy for gastric cancer.

Hejna M, Wöhrer S, Schmidinger M, Raderer M. Hejna M, et al. Oncologist. 2006 Feb;11(2):136-45. doi: 10.1634/theoncologist.11-2-136. Oncologist. 2006. PMID: 16476834 Free article. Review.

3

Palliative chemotherapy for recurrent and metastatic esophageal cancer.

Grünberger B, Raderer M, Schmidinger M, Hejna M. Grünberger B, et al. Among authors: hejna m. Anticancer Res. 2007 Jul-Aug;27(4C):2705-14. Anticancer Res. 2007. PMID: 17695436 Free article. Review.

4

The combination of 5-fluorouracil, leukovorin, etoposide, and cisplatin (FLEP) in patients with metastatic esophageal cancer. A single-institution experience.

Jonak C, Raderer M, Zacherl J, Prager G, Troch M, Ba-Ssalamah A, Hejna M. Jonak C, et al. Among authors: hejna m. Anticancer Res. 2008 Nov-Dec;28(6B):4101-4. Anticancer Res. 2008. PMID: 19192667 Free article.

5

Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna.

Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Bojic M, et al. Among authors: hejna m. Anticancer Res. 2011 Jun;31(6):2379-82. Anticancer Res. 2011. PMID: 21737668

6

Esophageal cancer: a critical evaluation of systemic second-line therapy.

Thallinger CM, Raderer M, Hejna M. Thallinger CM, et al. Among authors: hejna m. J Clin Oncol. 2011 Dec 10;29(35):4709-14. doi: 10.1200/JCO.2011.36.7599. Epub 2011 Nov 7. J Clin Oncol. 2011. PMID: 22067408 Review.

7

Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer.

Bartsch R, Woehrer S, Raderer M, Hejna M. Bartsch R, et al. Among authors: hejna m. Anticancer Res. 2006 Jul-Aug;26(4B):3187-90. Anticancer Res. 2006. PMID: 16886655 Free article.

8

Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.

Maresch J, Schoppmann SF, Thallinger CM, Zielinski CC, Hejna M. Maresch J, et al. Among authors: hejna m. Crit Rev Oncol Hematol. 2012 Jun;82(3):310-22. doi: 10.1016/j.critrevonc.2011.06.003. Epub 2011 Jul 23. Crit Rev Oncol Hematol. 2012. PMID: 21783379 Review.

9

Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.

Wöhrer S, Bartsch R, Hejna M, Drach J, Raderer M. Wöhrer S, et al. Among authors: hejna m. Scand J Gastroenterol. 2005 Oct;40(10):1222-5. doi: 10.1080/00365520510023440. Scand J Gastroenterol. 2005. PMID: 16265779

10

Stomach cancer and myositis ossificans-like lesions.

Maresch J, Hoffmann M, Raderer M, Hejna M. Maresch J, et al. Among authors: hejna m. J Clin Oncol. 2011 Jun 1;29(16):e481-2. doi: 10.1200/JCO.2010.34.4234. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444872 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters